Posterior Segment Age-related Macular Degeneration
mouse as an animal model for basal laminar deposit, Br J Ophthalmol, 2000;84:1415–19.
154. VandenLangenberg GM, Mares-Perlman JA, Klein R, et al., Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam eye study, Am J Epidemiol, 1998;148:204–14.
155. Smith W, Mitchell P, Leeder SR, Wang JJ, Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy – the Blue Mountains eye study, Arch Ophthalmol, 1998;116:583–7.
156. Anand R, Bressler SB, Davis MD, et al., Risk factors associated with age-related macular degeneration – a case–control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study report number 3, Ophthalmology, 2000;107:2224–32.
157. Milton RC, Clemons TE, Kurinij N, Sperduto RD, Age Related Eye Dis Study Research Group, Risk factors for the incidence of advanced age-related macular degeneration in the Age-related Eye Disease Study (AREDS) – AREDS report no. 19, Ophthalmology, 2005;112:533–9.
158. Delcourt C, Michel F, Colvez A, et al., Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study, Ophthalmic Epidemiol, 2001;8:237–49.
159. Seddon JM, Cote J, Davis N, Rosner B, Progression of age-related macular degeneration – association with body mass index, waist circumference, and waist–hip ratio, Arch Ophthalmol, 2003;121:785–92.
160. Hammond BR, Ciulla TA, Snodderly DM, Macular pigment density is reduced in obese subjects, Invest Ophthalmol Vis Sci, 2002;43:47–50.
161. Schaumberg DA, Christen WG, Hankinson SE, Glynn R, Body mass index and the incidence of visually significant age-related maculopathy in men, Arch Ophthalmol, 2001;119:1259–65.
162. Moeini HA, Masoudpour H, Ghanbari H, A study of the relation between body mass index and the incidence of age related macular degeneration, Br J Ophthalmol, 2005;89:964–6.
163. Klein R, Klein BEK, Franke T, The relationship of cardiovascular disease and its risk factors to age-related maculopathy – the Beaver Dam eye study, Ophthalmology, 1993;100:406–14.
164. Sato E, Feke GT, Appelbaum EY, et al., Association between systemic arterial stiffness and age-related macular degeneration, Graefes Arch Clin Exp Ophthalmol, 2006;244:963–71.
165. Tan JSL, Mitchell P, Smith W, Wang JJ, Cardiovascular risk factors and the long-term incidence of age-related macular degeneration – the Blue Mountains eye study, Ophthalmology, 2007;114:1143–50.
166. Seddon JM, George S, Rosner B, Rifai N, Progression of age-related macular degeneration – prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers, Arch Ophthalmol, 2005;123:774–82.
167. Seddon JM, Gensler G, Milton RC, et al., Association between C-reactive protein and age-related macular degeneration, JAMA, 2004;291:704–10.
168. Seddon JM, Gensler G, Klein ML, Milton RC, C-Reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration, Nutrition, 2006;22:441–3.
169. McCarty CA, Dowrick A, Cameron J, et al., Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study, BMC Ophthalmol, 2008;8:25.
170. Hyman L, Schachat A, He Q, Hypertension, cardiovascular disease,and age-related macular degeneration, Arch Ophthalmol, 2000;117:351–8.
171. Metelitsina TI, Grunwald JE, DuPont JC, Ying G-S, Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration, Br J Ophthalmol, 2006;90:342–6.
172. Hogg RE, Woodside JV, Gilchrist SECM, et al., Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization, Ophthalmology, 2008;115:1046–52.e1042.
173. Klein R, Klein B, Franke T, The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam eye study, Ophthalmology, 1993;100:406–14.
174. Klein R, Klein BEK, Jensen SC, The relation of cardiovascular disease and its risk factors to the 5-year incidence of age related maculopathy – the Beaver Dam eye study, Ophthalmology, 1997;104:1804–12.
175. Klein R, Klein BEK, Marino EK, et al., Early age-related maculopathy in the cardiovascular health study, Ophthalmology, 2003;110:25–33.
176. Wang S, Xu L, Jonas JB, et al., Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing eye study, Ophthalmology, 2009;116:2373–80.
177. Hall NF, Gale CR, Syddall H, et al., Risk of macular degeneration in users of statins: cross sectional study, Br Med J, 2001;323:375–6.
178. Wilson HL, Schwartz DM, Bhatt HRF, et al., Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration, Am J Ophthalmol, 2004;137:615–24.
179. McGwin GJ, Owsley C, Curcio C, Crain R, The association between statin use and age-related maculopathy, Br J Ophthalmol, 2003;87:1121–5.
152
180. McGwin JG, Xie A, Owsley C, The use of cholesterol-lowering medications and age-related macular degeneration, Ophthalmology, 2005;112:488–94.
181. Tan JSL, Mitchell P, Rochtchina E, Wang JJ, Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains eye study, Am J Ophthalmol, 2007;143:685–7.
182. Yilmaz MI, Baykal Y, Kilic M, et al., Effects of statins on oxidative stress, Biol Trace Elem Res, 2004;98:119–27.
183. Dithmar S, Curcio CA, Le NA, et al., Ultrastructural changes in Bruch’s membrane of apolipoprotein E-deficient mice, Invest Ophthalmol Vis Sci, 2000;41:2035–42.
184. Chuo JY, Wiens M, Etminan M, Maberley DA, Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies, Ophthalmic Epidemiol, 2007;14:367–74.
185. Kaiserman N, Vinker S, Kaiserman I, Statins do not decrease the risk for wet age-related macular degeneration, Curr Eye Res, 2009;34:304–10.
186. Maguire MG, Ying G-S, McCannel CA, et al., Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial, Ophthalmology, 2009;116:2381–5.
187. Smeeth L, Cook C, Chakravarthy U, et al., A case control study of age related macular degeneration and use of statins, Am J Ophthalmol, 2006;141:238.
188. Etminan M, Brophy JM, Maberley D, Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case–control study, Curr Drug Saf, 2008;3:24–6.
189. Scandinavian Simvastatin Survival Study Group, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), The Lancet, 1994;344:1383–9.
190. Christen WG, Glynn RJ, Chew EY, Buring JE, Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women, Ophthalmology, 2009;116:2386–92.
191. Christen W, Age-related macular degeneration (AMD) in a randomized trial of low dose aspirin, Invest Ophthalmol Vis Sci, 1997;38:S472.
192. Klein R, Klein B, Jensen S, et al., Medication use and the 5-year incidence of early age-related maculopathy, Arch Ophthalmol, 2001;119:1354–9.
193. Douglas IJ, Cook C, Chakravarthy U, et al., A case–control study of drug risk factors for age-related macular degeneration, Ophthalmology, 2007;114:1164–9.
194. van Leeuwen R, Tomany SC, Wang JJ, et al., Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents, Ophthalmology, 2004;111:1169–75.
195. Defay R, Pinchinat S, Lumbroso S, et al., Sex steroids and age-related macular degeneration in older French women: the POLA study, Ann Epidemiol, 2004;14:202–8.
196. Feskanich D, Cho E, Schaumberg DA, et al., Menopausal and reproductive factors and risk of age-related macular degeneration, Arch Ophthalmol, 2008;126:519–24.
197. Cousins SW, Marin-Castano ME, Espinosa-Heidmann DG, et al., Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice, Invest Ophthalmol Vis Sci, 2003;44:1221–9.
198. Rakic JM, Lambert V, Deprez M, et al., Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases, Invest Ophthalmol Vis Sci, 2003;44:1740–6.
199. Giansanti R, Fumelli C, Boemi M, Fumelli P, Age-related macular disease in diabetes mellitus, Arch Gerontol Geriatr, 1996;22(Suppl. 1):473–6.
200. Topouzis F, Anastasopoulos E, Augood C, et al., Association of diabetes with age-related macular degeneration in the EUREYE study, Br J Ophthalmol, 2009;93:1037–41.
201. Voutilainen-Kaunisto RM, Terasvirta ME, Uusitupa MI, Niskanen LK, Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance, Diabetes Care, 2000;23:1672–8.
202. Nagaoka T, Kitaya N, Sugawara R, et al., Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes, Br J Ophthalmol, 2004;88:1060–3.
203. Schocket LS, Brucker AJ, Niknam RM, et al., Foveolar choroidal hemodynamics in proliferative diabetic retinopathy, Int Ophthalmol, 2004;25:89–94.
204. Carresi C, Cruciani F, Paolucci F, et al., Montelparo study: risk factors for age-related macular degeneration in a little rural community in Italy, Clin Ter, 2009;160:e43–51.
205. Khan JC, Shahid H, Thurlby DA, et al., Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight, Br J Ophthalmol, 2006;90:29–32.
206. West SK, Rosenthal FS, Bressler NM, et al., Exposure to sunlight and other risk-factors for age-related macular degeneration, Arch Ophthalmol, 1989;107:875–9.
207. Delcourt C, Carriere I, Ponton-Sanchez A, Light exposure and the risk of age-related macular degeneration: the POLA study, Arch Ophthalmol, 2001;119:1463–8.
208. Darzins P, Mitchell P, Heller RF, Sun exposure and age-related macular degeneration. An Australian case–control study, Ophthalmology, 1997;104:770–6.
209. Taylor HR, West S, Munoz B, et al., The long-term effects of visible-light on the eye, Arch Ophthalmol, 1992;110:99–104.
210. Tomany SC, Cruickshanks KJ, Klein R, et al., Sunlight and the 10-year incidence of age-related maculopathy: the Beaver
Dam eye study, Arch Ophthalmol, 2004;122:750–7.
211. Mitchell P, Smith W, Wang JJ, Iris color, skin sun sensitivity, and age-related maculopathy – the Blue Mountains eye study, Ophthalmology, 1998;105:1359–63.
212. Wu J, Seregard S, Algvere PV, Photochemical damage of the retina, Surv Ophthalmol, 2006;51:461–81.
213. Algvere PV, Marshall J, Seregard S, Age-related maculopathy and the impact of blue light hazard, Acta Ophthalmol Scand, 2006;84:4–15.
214. Nirmalan PK, Katz J, Robin AL, et al., Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey, Invest Ophthalmol Vis Sci, 2004;45:4273–6.
215. Maltzman B, Mulvihill M, Greenbaum A, Senile macular degeneration and risk factors: a case–control study, Ann Ophthalmol, 1979;11:1197–201.
216. Gibson J, Shaw D, Rosenthal A, Senile cataract and senile macular degeneration: an investigation into possible risk factors, Trans Ophthalmol Soc UK, 1986;105:463–8.
217. Vinding T, Appleyard M, Nyboe J, Jensen G, Risk factor-analysis for atrophic and exudative age-related macular degeneration – an epidemiologic study of 1000 aged individuals, Acta Ophthalmol, 1992;70:66–72.
218. Starzycka M, Slomska J, Gorniak-Bednarz A, Ortyl E, [Risk factors for age-related macular degeneration], Klin Oczna, 1997;99:249–51.
219. Chen SJ, Cheng CY, Peng KL, et al., Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study, Invest Ophthalmol Vis Sci, 2008;49:3126–33.
220. CAPT, Risk factors for choroidal neovascularization and geographic atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial, Ophthalmology, 2008;115:1474–9.e1476.
221. Song SJ, Youm DJ, Chang Y, Yu HG, Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes, Ophthalmic Epidemiol, 2009;16:304–10.
222. Cugati S, Mitchell P, Rochtchina E, et al., Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains eye study, Ophthalmology, 2006;113:2020–5.
223. Klein R, Klein BEK, Wong T, et al., The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy, Arch Ophthalmol, 2002;120:1551–8.
224. Wang JJ, Klein R, Smith W, et al., Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies, Ophthalmology, 2003;110:1960–7.
225. Pollack A, Marcovich A, Bukelman A, Oliver M, Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation, Ophthalmology, 1996;103:1546–54.
226. Libre P, Intraoperative light toxicity: a possible explanantion for the association between cataract surgery and age-related macular degeneration, Am J Ophthalmol, 2003;136:961.
227. Armbrecht A, Findlay C, Aspinall P, et al., Cataract surgery in patients with age-related macular degeneration – one-year outcomes, J Cataract Refract Surg, 2003;29:686–93.
228. Chew EY, Sperduto RD, Milton RC, et al., Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study AREDS report 25, Ophthalmology, 2009;116:297–303.
229. Freeman EE, Munoz B, West SK, et al., Is there an association between cataract surgery and age- related macular degeneration? Data from three population-based studies, Am J Ophthalmol, 2003;135:849–56.
230. Clemons TE, Rankin MW, McBee WL, Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16, Arch Ophthalmol, 2006;124:537–43.
231. Baker ML, Wang JJ, Rogers S, et al., Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study, Arch Ophthalmol, 2009;127:667–73.
232. Wong TY, Klein R, Nieto FJ, et al., Is early age-related maculopathy related to cognitive function? The Atherosclerosis Risk in Communities Study, Am J Ophthalmol, 2002;134:828–35.
233. Pham TQ, Kifley A, Mitchell P, Wang JJ, Relation of age-related macular degeneration and cognitive impairment in an older population, Gerontology, 2006;52:353–8.
234. Klaver CCW, Ott A, Hofman A, et al., Is age-related maculopathy associated with alzheimer’s disease? The Rotterdam Study, Am J Epidemiol, 1999;150:963–8.
235. Anderson DH, Talaga KC, Rivest AJ, et al., Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration, Exp Eye Res, 2004;78:243–56.
236. McGeer PL, McGeer EG, Inflammation and the degenerative diseases of aging, Ann N Y Acad Sci, 2004;1035:104–16.
237. Rovner BW, Casten RJ, Leiby BE, Tasman WS, Activity loss is associated with cognitive decline in age-related macular degeneration, Alzheimers Dement, 2009;5:12–17.
238. Roca-Santiago HM, Lago-Bouza JR, Millan-Calenti JC, et al., [Alzheimer’s disease and age-related macular degeneration], Arch Soc Esp Oftalmol, 2006;81:73–8.
239. Tomany SC, Wang JJ, Van Leeuwen R, et al., Risk factors for incident age-related macular degeneration: pooled findings from 3 continents, Ophthalmology, 2004;111:1280–7.
240. Kaiserman I, Kaiserman N, Elhayany A, Vinker S, Risk factors for photodynamic therapy of predominantly classic choroidal
EUROPEAN OPHTHALMIC REVIEW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76